Advertise On EU-Digest

Anual Advertising Rates

4/12/17

PHARMAGEDDON: And few Americans even know that it’s happening

Big Pharma is America’s new mafia whose chemical warfare on humanity dwarfs the number of victims killed by all the world wars and acts of terrorism combined. While drug companies profit billions, people are dying by the millions. It makes you wonder if Pharmageddon is upon us with the next set of mandatory vaccinations planned by the Center for Disease Control (CDC) for the profit of drug companies.

Over 70% of Americans are on some form of pharmaceutical drug that often brings negative side-effects, including death. Iatrogenic death, or “death by doctor”, is considered the third leading cause of death in America, conservatively speaking. Some experts interpret the data to read iatrogenic death as the number one cause of death, and they have a great deal of evidence to back up the claim. These statistics suggest that we should change the name “health industry” to “illness industry.”

Conservative estimates suggest that America spends about 20% of the Gross Domestic Product (GDP) on health costs, about $3.35 trillion this year, which works out to $10,345 for every man, woman and child. Hospitals account for about 32%, doctors for 20%, and prescription drugs 10%.  Spending on prescription drugs in the U.S. rose to a record $425 billion in 2016.

The vaccine business alone is currently a $30 billion per year industry and the World Health Organization has urged increased vaccines, projecting that it will become a $100 billion per year industry by 2025. (See Global Vaccine Markets Features and Trends in stunning report.)

There are 57 granted U.S. patents with the CDC listed as an assignee. Some of the vaccine patents include: FluRotavirusHepatitis AHIVAnthraxRabies, Dengue feverWest Nile virusGroup A Strep, Pneumococcal diseaseMeningococcal diseaseRSVGastroenteritisJapanese encephalitisSARSRift Valley Fever, and chlamydophila pneumoniae, flavivirus infection, human rhinovirus, adjuvants, Canarypox virus, Fowlpox virus, Sealpox virus, and dog flu.

The global market for pharmaceuticals topped $1 trillion in sales in 2014. The world’s 10 largest drug companies generated $429.4 billion of that revenue. Five of the top 10 companies are headquartered in the U.S. are Johnson & Johnson, Pfizer, Abbot Laboratories, Merck, and Eli Lilly.
With the help of staggering profits and 1,100-plus paid lobbyists, the industry has gained powerful leverage on Capitol Hill. From 1998 to 2014,  

Big Pharma spent nearly $2.9 billion on lobbying expenses — more than any other industry. The industry also doled out more than $15 million in campaign contributions from 2013-14.  But the large amount of cash Big Pharma bestows on government representatives and regulatory bodies is small when compared with the billions it spends each year on direct-to-consumer advertising.

The U.S. is one of only two countries in the world whose governments allow prescription drugs to be advertised on TV.  A single manufacturer, Boehringer Ingelheim, spent $464 million advertising its blood thinner Pradaxa in 2011. The following year, the drug passed the $1 billion sales mark.
Big Pharma tends to weaken the objectivity of even the most honest health professionals while encouraging them to overprescribe medications. Consider the numbers:
  • Advertising instead of research: For every $1 spent on “basic research,” Big Pharma spends $19 on promotions and advertising.
  • Distribution of free drug samples: The U.S. has one pharmaceutical sales representative for every five office-based physicians.
  • Sponsorship of symposiums and medical conventions: Drug and medical device makers spend lavishly on doctors, including covering meals, travel, seminars and conventions that sometimes look more like vacations.
Bottom-line: The US Pharmaceutical Industry has become crooked to the core and many Democratic and Republican politicians are making sure to keep it that way

Read more: PHARMAGEDDON: And few Americans even know that it’s happening! | The Millennium Report

No comments: